Position in IBRX
as of Mar 31, 2026
· filed May 20, 2026
Position Value
$4,500,249
New position
Shares Held
586,734
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arete Wealth Advisors, LLC holds $5,119,069 across 2 Biotechnology names. IBRX ranks #1 (87.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
This page
|
586,734 | $4,500,249 | |
| 2 | ZVRA |
Zevra Therapeutics, Inc.
|
66,397 | $618,820 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,500,249 | 586,734 | Shares | Sole | 2026-05-20 | |
| No filing history on record for this holder in this stock. | ||||||